Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in FDA Trials!
Great headline, right?
The actual headline was: Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million
Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now Publicly Traded!
Sunset Capital Assets, Inc., (SNST), Executes and Completes Definitive Share Exchange Agreement with Aphex BioCleanse Systems Inc.
Our favorite...
American BriVision (ABVC) Reports Completion Clinical Trial for Treatment of Adult ADHD.
American BriVision (ABVC) Reports Completion of ABV-1505 Phase II Part I Clinical Trial for Treatment of Adult ADHD.
Last...
2020 Biotech Portfolio Soars 55%, We’re Amazed. Next Up: The Coming Gold Rush.
1. Yep, We Are Absolutely Amazed At The Biotech Stock Review's 2020 Watch List Performance – Especially In The Light Of...
Adding American BriVision (ABVC) $3.30 to Stocks We Expect Double List. $7.00 Price Potential.
Adding to Our 2020 Biotech 5-Pack, 5 Stocks We Expect to Double in 2020
Hapbee Closes $6.5 Million Private Placement and Provides Corporate Update.
VANCOUVER, BC, July 17, 2020 /PRNewswire/ - Hapbee Technologies, Inc. ("Hapbee" or the "Company"), a wellness technology company developing the revolutionary Hapbee wearable, is pleased to announce...
Immuron (IMRN) to Bank $20 Million.
Another Corona Virus Mania Makes Bank. This time $20 million into Immuron which once struggled, when it was trading near $2.00 just...
Robinhood and Robindhoodette.
The New Force on Wall Street.
It's not hedge funds, it's not program traders or AI-powered portfolio managers....
And Just Like That, We Have Another Double. iBio (IBIO).
$5.35 With 11 Million Shares Traded and it's Not Even 10:00!
Where is Citius Pharma (CTXR) in the FDA Approval Process?
We have a number of subscribers asking for an update on the FDA approval process for Mino-Lok. In layman's term (assuming approval)...
Latest article
Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.
119% Gain Post Split
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
(March 2024) When we finished writing our earlier...
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
